Is the US prepared to deal with another pandemic or widespread health crisis?
No, the United States is better prepared in some technical and logistical areas than before COVID-19 but remains incompletely prepared overall for another major pandemic or widespread health crisis. Significant gaps persist in leadership/coordination, sustained funding, public health workforce, data systems, political cohesion, and addressing systemic vulnerabilities exposed by COVID-19. Assessments from the GAO, bipartisan commissions, CDC, and others paint a mixed picture: progress has been made, but many recommendations remain unimplemented, and momentum has waned amid political transitions and competing priorities.[1]
Key Improvements
Post-COVID investments and reforms have strengthened certain capabilities:
These changes mean the U.S. could detect and begin countering certain threats (e.g., known influenza strains or mpox-like viruses) more quickly than in early 2020, with better stockpiles of basics and manufacturing surge potential.
Persistent and Significant Gaps
Multiple authoritative reviews highlight unfinished business:
Broader Context and Outlook
COVID-19 killed over 1 million Americans and revealed deep inequities, supply fragility, data silos, and trust deficits. The U.S. excelled relatively in vaccine development/rollout speed and economic recovery support compared to some peers, but excess mortality and response inconsistencies were high.[8]
Threats are real and evolving: zoonotic spillover (e.g., H5N1), antimicrobial resistance, climate-driven changes, lab accidents, and potential bioweapons (amplified by AI/biotech advances). Preparedness is not binary—it is a continuum of capabilities that degrade without sustained investment.
Bottom line: The U.S. has stronger stockpiles, better data tools, R&D platforms, and some institutional memory than in 2019. It is more prepared for certain familiar threats or moderate scenarios. However, for a severe novel pandemic (high transmissibility + severity, or simultaneous crises), major shortfalls in workforce, seamless whole-of-government leadership, sustained funding, public compliance, and equity would likely cause significant failures again. Experts (GAO, Biodefense Commission, Independent panels) consistently urge treating this as a national security priority with multi-year funding, clear authority, exercises that drive real change, and depoliticized science. Without that, “prepared” remains aspirational rather than assured. Progress is reversible with budget cuts or neglect, as recent fluctuations demonstrate.
Citations (8)
- https://www.gao.gov/products/gao-24-107175
Backs: “Assessments from the GAO, bipartisan commissions, CDC, and others paint a mixed picture: progress has been made, but many recommendations remain unimplemented, and momentum has waned amid political transitions and competing priorities.”
evidence, official document, points to no. Claim: GAO and other assessments show a mixed picture: progress made but many recommendations unimplemented and momentum waning, leaving the US incompletely prepared.[1]
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Domestic manufacturing and “warm base” lab partnerships for surge testing have expanded.”
statistic, official document, points to yes. Claim: The Strategic National Stockpile was restocked to roughly 70 times the N95 respirators and 10 times the ventilators of pre-pandemic levels, and supported mpox and H5N1 responses.
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC has reorganized for better integration (e.g., merging flu/COVID efforts) and created public-private lab partnerships for rapid test development.”
statistic, official document, points to yes. Claim: Electronic case reporting grew from under 200 facilities in 2020 to over 45,000 by 2024, with improved wastewater surveillance and forecasting.
- https://www.niaid.nih.gov/news-events/nih-awards-establish-pandemic-preparedness-research-network
Backs: “Global efforts include U.S. pledges to the Pandemic Fund and support for pathogen prioritization frameworks. NIH and others fund proactive R&D on virus families.”
evidence, article, points to yes. Claim: Institutional gains include NIH-funded proactive research on virus families and a pandemic preparedness research network.
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Many prior Commission recommendations saw only partial or no action.”
evidence, article, points to no. Claim: The Bipartisan Commission on Biodefense's 2024 blueprint urges immediate action; GAO recommendations remain open and many prior recommendations saw partial or no action.
- https://justthenews.com/government/white-house/after-outbreaks-trump-admin-restarts-office-pandemic-preparedness-and
Backs: “Political polarization, eroded public trust in institutions, and misinformation remain major barriers to coherent action (e.g., masking, vaccination, lockdowns).”
evidence, article, points to no. Claim: The Office of Pandemic Preparedness and Response Policy faced severe staffing cuts after the 2025 administration change, later restarted amid outbreaks.
- https://www.cidrap.umn.edu/public-health/gao-public-health-workforce-shortage-undermines-ability-respond-outbreaks-other
Backs: “This undermines detection, contact tracing, surge response, and routine functions.”
statistic, article, points to no. Claim: State and local public health departments need roughly 80,000 more FTEs; workforce shortages undermine outbreak response.
- https://www.brookings.edu/articles/the-us-recovery-from-covid-19-in-international-comparison/
Backs: “The U.S. excelled relatively in vaccine development/rollout speed and economic recovery support compared to some peers, but excess mortality and response inconsistencies were high.”
evidence, article, neutral. Claim: The US excelled at vaccine development and economic recovery relative to peers, but excess mortality and response inconsistencies were high.